News
AAPG ▲ +3.6% - Ascentage Pharma Group Internat
AAPG ▲ +3.6% - Ascentage Pharma Group Internat
$AAPG - Ascentage Pharma’s Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL
20-OCT-2026 07:30 PM ET
Share this post
More filings for $AAPG
View full $AAPG filing history →💬 Comments
Loading comments…
Leave a comment
